LivaNova (LIVN) Other Non Operating Income (2014 - 2025)
LivaNova (LIVN) reported Other Non Operating Income of -$2.7 million for Q2 2025, up 12.94% on a YoY basis from -$2.3 million in Q2 2024, and down 123.22% sequentially from $11.4 million in Q1 2025.
LivaNova (LIVN) Other Non Operating Income (2014 - 2025) Analysis & Trends
LivaNova (LIVN) has 12 years of Other Non Operating Income data on file, last reported at -$2.7 million in Q2 2025.
- For the quarter ending Q2 2025, Other Non Operating Income rose 12.94% year-over-year to -$2.7 million; the trailing twelve-month figure through Dec 2025 stood at $8.8 million (up 130.73% YoY), and the FY2025 full-year result was -$2.7 million, up 89.6% from the prior year.
- Other Non Operating Income retreated to -$2.7 million in Q2 2025, from $11.4 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $38.5 million in Q3 2022 to a low of -$25.5 million in Q1 2024.
- A 5-year average of $2.0 million and a median of $2.2 million in 2022 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income plunged 523.58% in 2021 and surged 583.26% in 2022, its largest moves.
- Tracing LIVN's Other Non Operating Income over 5 years: stood at -$20.7 million in 2021, then jumped by 127.98% to $5.8 million in 2022, then jumped by 47.54% to $8.5 million in 2023, then tumbled by 135.61% to -$3.0 million in 2024, then advanced by 12.94% to -$2.7 million in 2025.
- Business Quant data shows LIVN's Other Non Operating Income at -$2.7 million in Q2 2025, $11.4 million in Q1 2025, and -$3.0 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn |
| 10 | LivaNova | 4.38 Bn | 3.84 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -2.65 Mn |
| Mar 31, 2025 | 11.42 Mn |
| Jun 30, 2024 | -3.05 Mn |
| Mar 31, 2024 | -25.48 Mn |
| Sep 30, 2023 | 8.55 Mn |
| Jun 30, 2023 | 2.71 Mn |
| Dec 31, 2022 | 5.80 Mn |
| Sep 30, 2022 | 38.53 Mn |
| Jun 30, 2022 | 1.63 Mn |
| Mar 31, 2022 | 3.90 Mn |
| Dec 31, 2021 | -20.71 Mn |
| Sep 30, 2021 | 13.61 Mn |
| Jun 30, 2021 | 239,000.00 |
| Mar 31, 2021 | -6.44 Mn |
| Dec 31, 2020 | -3.32 Mn |
| Sep 30, 2020 | 3.42 Mn |
| Jun 30, 2020 | -999,000.00 |
| Mar 31, 2020 | -1.91 Mn |
| Dec 31, 2019 | 795,000.00 |
| Sep 30, 2019 | 327,000.00 |